Literature DB >> 12867662

Up-regulation of cathepsin B and cathepsin L activities in scrapie-infected mouse Neuro2a cells.

Yonghua Zhang1,2, Eberhard Spiess3, Martin H Groschup3, Alexander Bürkle1,2.   

Abstract

Prion diseases are characterized by the accumulation of an abnormal, proteinase K-resistant isoform of the prion protein, PrP(Sc), which is generated by a post-translational conversion of the protease-sensitive normal cell-surface glycoprotein PrP(c) involving major conformational changes. The conversion is thought to occur at the plasma membrane or along the endocytic pathway towards the lysosome. PrP(Sc) aggregates have been found to accumulate in secondary lysosomes. In our study, the activities of two major lysosomal cysteine proteases, cathepsins B and L, were found to be significantly increased in scrapie-infected Neuro2a cells compared with uninfected cells using biochemical and cytochemical methods. We hypothesize that lysosomal proteases may be involved in a 'second autocatalytic loop' of PrP(Sc) formation, acting in concert with the well-known autocatalytic enhancement of PrP conversion in the presence of PrP(Sc).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867662     DOI: 10.1099/vir.0.19153-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  Near-infrared fluorescence imaging of apoptotic neuronal cell death in a live animal model of prion disease.

Authors:  Victoria A Lawson; Cathryn L Haigh; Blaine Roberts; Vijaya B Kenche; Helen M J Klemm; Colin L Masters; Steven J Collins; Kevin J Barnham; Simon C Drew
Journal:  ACS Chem Neurosci       Date:  2010-09-30       Impact factor: 4.418

2.  Cardiac glycoside-mediated turnover of Na, K-ATPases as a rational approach to reducing cell surface levels of the cellular prion protein.

Authors:  Mohadeseh Mehrabian; Xinzhu Wang; Shehab Eid; Bei Qi Yan; Mark Grinberg; Murdock Siegner; Christopher Sackmann; Muhammad Sulman; Wenda Zhao; Declan Williams; Gerold Schmitt-Ulms
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

3.  Scrapie protein degradation by cysteine proteases in CD11c+ dendritic cells and GT1-1 neuronal cells.

Authors:  Katarina M Luhr; Elin K Nordström; Peter Löw; Hans-Gustaf Ljunggren; Albert Taraboulos; Krister Kristensson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 4.  Prion protein biosynthesis and its emerging role in neurodegeneration.

Authors:  Oishee Chakrabarti; Aarthi Ashok; Ramanujan S Hegde
Journal:  Trends Biochem Sci       Date:  2009-05-15       Impact factor: 13.807

5.  Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.

Authors:  Tehila Mayer-Sonnenfeld; Dana Avrahami; Yael Friedman-Levi; Ruth Gabizon
Journal:  Cell Mol Neurobiol       Date:  2008-03-19       Impact factor: 5.046

6.  Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology.

Authors:  Wei Xiang; Otto Windl; Gerda Wünsch; Martin Dugas; Alexander Kohlmann; Nicola Dierkes; Ingo M Westner; Hans A Kretzschmar
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 7.  Prions: protein only or something more? Overview of potential prion cofactors.

Authors:  Carlo Fasano; Vincenza Campana; Chiara Zurzolo
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

8.  Prion disease induced alterations in gene expression in spleen and brain prior to clinical symptoms.

Authors:  Hyeon O Kim; Greg P Snyder; Tyler M Blazey; Richard E Race; Bruce Chesebro; Pamela J Skinner
Journal:  Adv Appl Bioinform Chem       Date:  2008-09-07

9.  Selective processing and metabolism of disease-causing mutant prion proteins.

Authors:  Aarthi Ashok; Ramanujan S Hegde
Journal:  PLoS Pathog       Date:  2009-06-19       Impact factor: 6.823

10.  Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane.

Authors:  Rob Goold; Chris McKinnon; Samira Rabbanian; John Collinge; Giampietro Schiavo; Sarah J Tabrizi
Journal:  J Cell Sci       Date:  2013-06-26       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.